PHOTOGRAPHIC IMMUNOFLUORESCENT ASSAY

Abstract: A luminescent assay process characterized in that images of a selectively luminescent sample are recorded on a photographic film by macrophotography.

Description: PHgτgG^PHIC_i yNOFLUORESCENT_ASSAY This invention is concerned with improvements in or relating to luminescent assays, e.g. fluorescent assays. In particular, the present invention relates to a process for conducting fluorescent assays for materials in biological samples and to a means for use in such assays. Immunoassays and other assay methods which take advantage of the specific binding reaction between a specific binding reagent such as an antibody or antigen and its specific binding partner such as an antigen or antibody are generally known as are such methods in which the presence or absence in a sample of the specific binding agent is detected by use of a fluorescent label. In essence, such assay methods comprise contacting a known specific binding partner with a sample suspected to contain a specific binding agent, permitting the specific binding partner and agent to interact and detecting the interaction by use of a fluorescent labelling technique. One example of such a process is a direct immunoassay for the detection of antigens in tissues or cells according to which an immobilised sample containing the suspected antigen is contacted with a corresponding antibody which has been conjugated with a fluorochrome, the fluorescently-labelled antibody being immobilised on a support; areas on the support of enhanced fluorescence indicate where the antigen-antibody reaction has taken place and thus the presence, in the sample, of the suspected antigen. As well as this direct assay method, there is also available an indirect (sandwich) immunoassay method in which a serum or other body fluid which may contain, for example, an antibody to be detected, is first contacted with the complementary antigen immobilised on a support followed by washing to remove unreacted material; any of the antibody present reacts with the immobilised antigen binding the antibody to it. The immobilised antigen/antibody complex is then contacted with appropriate anti-serum containing antibodies conjugated with the fluorochrome; areas of enhanced fluorescence on the support indicate the presence of the suspected antibody. A similar indirect method is available for the detection of antigens, again in body fluids, but more usually in tissue or cells, employing the corresponding immobilised antibody. Other direct and indirect methods for the detection of antigens and antibodies or other specific binding agents using their corresponding specific binding partners are available and the principle is well known to those skilled in the art. A particular micro-immunofluorescent sandwich technique has previously been reported in which antigens are immobilised in the form of micro-dots on a microscope slide. The test is conducted by contacting the microscope slide with the test sample, for instance a body fluid or, tissue or cell suspension. Such techniques are referred to, for example, in the following papers: Wang and Grayston, American Journal of Ophthalmology, pp 367-374, September 1970. Dwyer - t a_l. , British Journal of Venereal Diseases £8 pp 452-459. (1972). Terharne t e . , Journal of Clinical Pathology, 3_0 pp 510-517 (1977). Darougar e_t al_ . , British Journal of Ophthamology, 6_2 pp 503-508 (1978) . Terharne et al ^ . , British Journal of Venereal Diseases 5_4 pp 403-408 (1978) . Forsey and Darougar, Journal of Clinical Pathology, 3_3 pp 171-176 (1980) . Forsey and Darougar, British Journal of Ophthalo ology 6_8 pp 409-411 (1984) . Forsey et_ al., Journal of Infection 1_2 pp 145-152 (1986). This micro-immunofluorescent technique can be used for example for the detection of antibodies against any of chlamydia, adenoviruses, herpes simplex virus, human immunodeficiency virus (AIDS), hepatitis B, syphilis and mycoplasma. The results of the above mentioned assay methods are commonly assessed by technical staff viewing a slide through a microscope, a tedious and subjective procedure requiring a high level of training and experience. It is an object of the present invention to provide an improved luminescent assay method. Other examples of luminescence besides fluorescence include che iluminescence and bioluminescence. Surprisingly I have found that objectively assessable results can be obtained rapidly by a simple photographic technique. The invention provides a luminescent assay method, characterised in that images of a selectively luminescent sample are recorded on a photographic film by macrophotography as defined herein. By the expression "macrophotography as defined herein" I mean photography in which the magnification between the sample and the image on the film is from 1 x up to a maximum magnification falling well below microscopic levels. It has now surprisingly been found that both the accuracy and the ease of reading the results of such assay methods can be enhanced by conducting the assay on microscope slides containing one of more test patches each of which has a control spot and various test spots and reading and recording the results photographically. The invention also provides a fluorescent assay method comprising the steps of subjecting a sample selectively stained with a fluorochrome to radiation of exciting wavelengths so that the fluorochrome is excited to emit radiation at its emitting wavelengths, and recording images of the excited sample on a photographic film by macrophotography as defined herein. In particular, the present invention provides a diagnostic test process comprising; (a) contacting a test patch with a sample suspected to contain one or more specific binding agents, the test patch comprising at least one control spot and at least one test spot, the test spot or spots each comprising a specific binding partner for a specific binding agent to be detected, (b) permitting the specific binding agents in the sample to react with or adhere to their complementary specific binding partners of the test patch, (c) labelling with a fluorescent label any test spot which has reacted with, or to which is adhering, a specific binding agent, (d) stimulating such labelled test spots to fluoresce, (e) photographically recording the fluorescence from the test patch such that a single photographic frame contains an image of the fluoresence from the whole of at least one test patch and such that the image is on a scale such that each fluorescent labelled test spot within the test patch is visible to the unaided human eye. The process of the present invention obviates the need to use a microscope to collect sufficient light for the human eye to distinguish the results of the control and SU B ST ITUTE SHEET test spots and has the additional benefits of speed especially in handling multiple tests simultaneously, and of providing a permanent record. In accordance with the present invention, the test will normally be conducted on a substrate, such as a microscope slide, containing at least one and usually a number of test patches. Each test patch consists of an area for receiving a sample fluid and a plurality of spots. Each spot is a "micro-dot" either of a control substance or a test substance. The spots containing a test substance (hereafter "test spots") will comprise a specific binding partner immobilised on the substrate, where necessary in association with additional agents essential for detection of the reaction between the specific binding partner and the specific binding agent to be detected. Usually the test spots will comprise an antigen or antibody and an agent for binding the antigen or antibody to the substrate. The test patch also comprises at least one control spot; this is present to provide a negative control and it is expected that the control spot will not react or will only react slightly with any component of the sample under test. If a reaction of the control spot is observed to be similar to that of a test spot, or if the control spot becomes bright this suggests that there is a defect in the test patch, the sample tested or in the test methodology so that the result is null. The control spot will usually consist of all the components used in the SUBSTITUTE SHEET formation of a test spot except for the specific binding partner intended to detect a specific binding agent in the test sample. The exact nature of both the control and test spots will depend upon the nature of the specific binding agent to be detected and the nature of the available_ specific binding partners complementary thereto as well as the means available for fluorescently labelling any test spot which has reacted with, or to which is adhering, a specific binding agent in the test sample. Such considerations are generally well known to those skilled in the art who will be able to identify suitable specific binding partners for detecting particular specific binding agents in a sample, means for immobilising the specific binding partners on a suitable subject and means for fluorescently labelling the test spots after reaction with the specific binding reagents. The skilled person will also be aware of the conditions necessary to stimulate fluorescence in the particular fluorescent labels selected for use in the test process. The photographic recording step is critical to the present invention and there are various photographic methods which will be available to those skilled in the art for conducting this step. In a preferred embodiment of the invention, the fluorescence is recorded photographically at a magnification of, preferably, 1 to 10 x to provide a negative or positive image which is directly readable by SU i 8 U a & a>h the unaided human eye. It is particularly preferred to use a magnification of from 1 to 10 x together with instant development film to provide a positive image which may be read by the unaided human eye; more preferably the image is produced at from 1 to 5 x and most preferably at 1.5 to 5 x magnification. Materials for use in the present invention, particularly microscope slides containing at least one test patch, for instance, 2, 4, 6, 8 or 10 test patches, each containing a control spot and at least one for instance 2, 3, 5, 7 or 9 test spots may be produced as illustrated in the references mentioned above and, preferably using the apparatus described in co-pending British patent application no. 8809611.0. The maximum number of test spots in a patch is limited by the minimum detectable fluorescence required to provide a photographic record, by the size of the support member bearing the test patches and by the number of test patches on the support member. On a microscope slide containing an array of 6x3 test patches it has been possible to use up to 18 test spots per patch and this may be further increased with improved spotting techniques. The invention also provides a fluorescent assay method comprising the steps of subjecting a sample selectively stained with a fluorochrome to radiation of exciting wavelengths so that the fluorochrome is excited to emit radiation at its emitting wavelengths, and ' •—- - i j ~^J ■ > ^ -i l_j photographically recording images of the excited sample as hereinbefore described. The invention also provides a fluorescent assay method for use in medical science comprising the steps of subjecting a sample selectively stained with a fluorochrome to radiation of exciting wavelengths so that the fluorochrome is excited to emit radiation at its emitting wavelengths, photographically recording images of the excited sample, and suppressing radiation of the exciting wavelengths between, the sample and the photographic film. The exciting radiation is for example in the range of ultraviolet (UV), UV-violet, blue-violet, blue and green. The corresponding exciting wavelengths are for example: UV ca.365 nm. UV-violet 390-420 n . Blue-violet 395-440 nm. Blue 450-490 nm. Green 515-565 nm. The sample may be derived from humans or animals. Examples of fluorescent assays include for example assays for antigens, antibodies, DNA, nucleic acids, biogenic amines e.g. catecholamine, primary amines, thrombocytes, lyεiαeε, histoπes, lymphocytes, leucocytes, cell nuclei, cell walls, ucus, albumen, cellulose, bone tissue, polychromes, osteons, chromosomes as well as chlamydia, viruses and bacteria. HP IT r* ■ ~3vt it^k i- :τ The use of a sophisticated photomicroscope for the study of fluorescent samples is known but this involves microphotography at a magnification of say 400 x with a correspondingly reduced optical field of view, and it is not practicable for rapid assessment of the results of e.g. diagnostic tests. In embodiments where the fluorescent assay in an indirect immunoassay for the detection of antigen-antibody reactions, the provision of the selectively stained sample comprises the steps of contacting a serum or other body fluid which may contain an antibody or antigen to be detected, with a complementary immobilised antigen or antibody, respectively; and then contacting the immobilised material with an appropriate anti-serum conjugated with the fluorochrome. The complementary antigen or antibody may be immobilised in the form of discrete micro-dots on a slide. The diameter of the micro-dots is for example 0.5-3mm. Each plurality of the discrete micro-dots may contain a respective different complementary antibody or antigen, to provide a simultaneous assay for plurality of different antigen or antibodies. Preferably the photographic film used is a fast monochromatic film up to for example 20,000 ASA. The exposure is for example from 1 to 60 seconds e.g. from 2 to 20 seconds, and the aperture of from f2.8 to f22, e.g. from flδ to f22. One preferred exposure is 2 seconds at f5.6 with 20,000 ASA film. S UBSTITUTE SHEET / B88/00642 The invention also comprehends apparatus constructed, arranged and adapted to operate in carrying out a method according to the invention. There now follows a description to be read with reference to the accompanying drawings of apparatus embodying the invention. This description which is also illustrative of method aspects of the invention is given by way of example only and not by way of limitation thereof. In the accompanying drawings: Figure 1 shows an outside front view of the apparatus embodying the invention; Figure 2 shows a side view corresponding to Figure 1; Figure 3 is a diagrammatic view illustrating the optical arrangement of the apparatus; Figures 4 and 5 illustrate a locking and shutter mechanism of the apparatus; Figure 6 shows a plan view of a slide supporting assembly of the apparatus; and Figure 7 shows a drawing of a photograph of a sli The apparatus comprises a casing 10 comprising 5TSTU7 " -E _ \i Sm __ m jj a rear enclosure 12 housing a transformer (not shown) an adjustable timer 14, a power supply switch 16 and a push button switch 18, all of which are mounted on a front panel 20 of the rear enclosure 12. The housing also comprises a light-tight front enclosure 22 on which is mounted a camera 24. The enclosure 22 also houses two symmetrically arranged projector lamps 26 (Figure 3) each followed by an incident lens assembly 28. In the operation of the apparatus a transparent slide 30 with a fluorochrome stained sample thereon is supported in the enclosure 22 directly below the camera 24, by a removable support assembly 32; each incident lens assembly 28 is provided between its lamp 26 and the slide 30. An objective lens assembly 34 is mounted immediately below the camera 24 between the camera 24 and the slide 30. In the operation of the apparatus a parallel beam- of light from each lamp 26 impinges on the slide 30 via the incident lens assembly 28 and are reflected into the camera 24 via the objective lens assembly 34. Each lamp 26 is a 100 watt tungsten halogen projector lamp type A1/231 (ANSI code ETP) with a dichroic backing; the lamp is adapted to generate radiation at the fluorochrome's exciting wavelengths. Each lens assembly 28 comprises a heat filter 36, - ι 3 - followed by a bi-concave lens 38 and an exciter filter 40, adapted to selectively transmit the exciting wavelengths generated by the lamp to the fluorochrome on the slide;excitation of the fluorochrome causes it to emit radiation at its emitting wavelengths which are usually longer than the exciting wavelengths. The objective lens assembly 34 comprises a flat field objective lens 42 followed by a barrier filter 44 adapted to suppress reflected radiation o the exciting wavelengths between the sample and film in the camera while transmitting to the film radiation of the emitting wavelengths. The objective lens assembly 34 provides a magnification at the film well below microscopic levels. The camera 24 is of the instant development type e.g. Polaroid and comprises a camera back assembly 46, loaded with the film in the plane P. The removable slide support assembly 32 is adapted to slide between horizontal inverted L-shaped runners 48 fixed in the enclosure 22. The assembly 32 comprises a trapezoidal vertical plate 50 adapted for light-tight engagement with a corresponding aperture in the enclosure 22. Secured to the plate 50 is a pedestal 52 shaped for mating engagement between the runners 48. Mounted on the pedestal 52 is a slide holder 54 in which the slide is held in the operation of the apparatus by a spring-urged arm 56 which retains the slide in position in a slot 59 spaced from the arm 56. The slide holder 54 comprises a well 55 (Figures 5 and 6) below the plane of the slide; the interior surface of the well 55 is matt, opaque and black and provides an optical background to the slide; a horizontal portion 57 of the interior surface parallel to the slide is spaced therefrom to avoid optical scatter. The slide support assembly 32 is locked in a closed position in the operation of the apparatus by rotation of a knurled knob 5δ mounted on the plate 50. The knob 58 is arranged to operate a locking mechanism comprisirrg a circular disc 60 (Figure 4) * mounted on the rear of the plate 50 for rotation by the knob 58. The disc 60 is pivotally linked to sliding bolts 62 which are arranged to slide in brackets 64 between an unlocked position (Figure 4) and a locked position in which the bolts 62 engage behind portions of the enclosure 22 which define the aperture in the enclosure which is closed by the plate 50. It will be realised that anti-clockwise (Figure 4) rotation of the disc 60 moves the bolts 62 from their unlocked position to their locked position. This anti-clockwise rotation of the disc 60 also operates a shutter 66 (Figures 1 and 2) of the camera 24 via a pivotal link 68 (Figures 4 and 5), a lever 70 pivoted at_.72 and a push rod 74, a collar 76 of which engages the lever 70 remotely from the pivot 72. Upper and lower positions of the collar 76 are shown in Figures ' and 2. The shutter 66 is hinged at 78 and is spring urged into a horizontal, closed, position. The push rod 74 extends through a guide 80 to engage the shutter to the right (Figure 2) of the hinge 78, and it will be realized that anti-clockwise rotation of the disc 60 by operation of the knob 58 lifts the push rod 74 via the link 68 , lever 70 and collar 76 tc open the shutter 66 about its hinge 78, so that there is a clear optical path from the slide to the film. The operation of the apparatus will now be summarised from a condition in which the slide support assembly 32 has been removed f ee: the enclosure 22, the camera shutter 66 is closed, and light cannot enter the camera 24. A slide containing a selectively fluorescent sample for assay is mounted on the slide holder 54; the support assembly is slid into the enclosure 22 and locked in its closed position by rotation of the knob 58, which simultaneously causes opening of the shutter 66; but since the enclosure 22 is now light-tight, light can still not enter the camera 24. The power is now switched on by operation of the switch 16, the desired exposure is set en the timer 1 , and the push button .8 is pressed tc initiate the V?»9 _ _~_ ^~~' : ?~~--^ ~\~ exposure cycle which commences with switching on the lamps 26, and terminates with them being switched off by operation of the timer 14. The exposed film is developed in the usual manner and removed from the camera back 46. Images of the sample are recorded on the developed film and where they clearly show areas of specially enhanced fluorescence provide for a rapid objective assessment of the assay results. Alternative arrangements of the apparatus are envisaged whereby, for example, the power supply is provided by internal or external primary or secondary batteries and approp iately rated lamps are selected according to the power supply. Moreover, for processing large numbers of slides the slide support assembly would be replaced by means for sequentially moving one of a series of slides into position beneath the camera, light sealing the exposure chamber and initiating exposure before expelling that slide and drawing another slide into position. The Table illustrates by way of example approximate exciting and emitting wavelengths from which appropriate exciting and barrier filters may be selected for use with various fluorochromes . VJ ι _ TABLE Excitation Fluorochrome Range Excitation Emission Colour Fluorescein isothiocyanate blue 450-490 nm 515 nm Tetramethyl rhodamine isothiocynate green 515-565 nm 7 590 nm Lissamine rhodamine B green ca. 546 nm 7590 nm Dinaphthyl aminosulfonic acid UV ca. 365 nm 397 nm Bisaminophenyl oxadiazole UV ca. 365 nm 7397 nm Acriflavine blue-violet ca. 436 nm 20 nm Pararosaniline green ca. 546 nm ^• 590 nm Fluoroescamine UV ca. 3 5 nm 7397 nm Mepacrine blue-violet 395-440 nm 7H7O nm Dansyl chloride UV ca. 365 nm • 7 -397 nm Sulphaflavine UV ca. 365 nm - 397 nm Euchrysine blue-violet ca. 1)36 nm ;>■ 520 nm Thioflavine S blue-violet ca. 36 nm > 520 nm Coriphosphine blue 450-490 nm >520 nm Methyl green pyronine stilbene green ca. 546 nm ✓* 590 nm Acridine orange blue 450-490 nm >520 nm Berberine sulphate blue-violet ca. 36 nm >520 nm Mithramycine UV-violet 390-420 nm 7 50 nm Phosphine 3 R blue-violet ca. 436 nm 520 nm Aurophosphine G blue-violet ca. 436 nm 7-520 nm Thiazine red R green 515-565 n >590 nm Auramine blue H50-- . 90 nm / 520 nm Acridine yellow blue blue-violet 436-H90 nm - 5 0 nm Primuline 0 blue-violet 395-440 nm 7- 1.70 nm TABLE ( continued ) Tetracycline blue-violet blue 395-440 no 7>- 70 nm Calceine UV ca. 3&5 nn 7397 nm Xylene orange green ca. 546 nm 7-590 nm Acid fuchsine green ca. 546 nm 7590 nm Quinacrine blue-violet ca. 36 rim ^470 Example An indirect (sandwich) assay was carried out for chlamydial antibodies. A transparent glass slide (Figure 7) of the usual rectangular form was provided with highly clean glass coated with Teflon (100). Eighteen evenly spaced circular wells 112 were provided on the slide, the wells 112 being free of the Teflon coating. which is provided to prevent spreading of liquid outside the wells during the testing procedure. Each well 112 contains six discrete micro-dots; each of five of the dots comprises a different variety of purified immobilised chlamydial antigen and the sixth is a negative control free of chlamydial antigen. In carrying out the procedure. a human serum to be tested was introduced into a well 112, incubated at 37°C, washed off with phosphate buffered saline pH 7-3, and dried; any antibodies in the serum complementar to the antigens of the dots were retained on the dots by the antigen-antibody reaction; swine anti-human IgG conjugated with fluorescein isothiocyanate was then introduced into the well 112, again incubated at 37°C washed off with phosphate buffered saline pH 7-3, and dried; the conjugated anti-serum attached to any serum antibodies retained on the cots. Different SUBSg 1 iU a £. Sr.s_.s_i dilutions of the serum were used in 17 of the respective different wells 112, and a positive control serum known t contain chlamydial antibodies was used in the eighteenth wel For further details reference may be made for example to Forsey and Darougar, Journal of Clinical Pathology 3J3 pages 171-176 (1980) referred to hereinabove The slide was then photographed in the apparatus described with reference to Figures 1-6 of the drawings with an exposure of 7-5 seconds, aperture f8, magnification 2x and monochromatic film 20,000 ASA to give the results illustrated in Figure 7. The bright dots are images of selectively fluorescent areas of the sample and indicate positive readings. The exciting and barrier filters used were Zeiss (West Germany) 48 77 09 BP (Pass Band) 450-490 n and B? (Pass Band) 515-565 nm respectively. It will be realized that the exciting radiation is in the blue range. Similar results were obtained in detecting anti- bodies against herpes simplex, adenoviruses, and human immunodeficiency virus (AIDS). In a modification each well contains seven discrete micro-dots each containing a respective differe antigen: thus one dot contains chlamydial antigen; another, adenovirus antigen; another, herpes simplex < -s * -_ -ua -S virus antigen; another, human immunodeficiency virus antigen (AIDS); another, hepatitis B antigen; another, syphilis antigen, and the remaining one, mycoplasma antigen. This provides for a simultaneous assay for the seven corresponding antibodies. The method may be amended in order simultaneously to test different sera or even to test a dilution series of each of serveral sera.

Claims: CLAIMS 1. A luminescent assay process characterised in that images of a selectively luminescent sample are recorded on a photographic film by macrophotography. 2. A diagnostic test process comprising: (a) contacting a test patch with a sample suspected to contain one or more specific binding agents, the test patch comprising at least one control spot and at least one test spot, the test spot or spots each comprising a specific binding partner for a specific binding agent to be detected, (b) permitting the specific binding agents in the sample to react with or adhere to their complementary specific binding partners of the test patch, (c) labelling with a fluorescent label any test spot which has reacted with, or to which is adhering, a specific binding agent, (d) stimulating such labelled test spots to fluoresce, (e) photographically recording the fluorescence from the test patch such that a single photographic frame contains an image of the fluoresence from the whole of at least one test patch and such that the image is on a scale such that each fluorescent labelled test spot within the test patch is visible to the unaided human eye. 3. A process according to claim 1 or claim 2 wherein the image is formed at a magnification of 1 to lOx and is directly readable by the unaided human eye. 4. A process according to claim 3 wherein the magnification is 1.5 to 5x. 5. A process according to any one of claims 1 to 4 wherein the process is conducted using a microscope slide bearing an array of up to 6x3 test patches each containing up to 18 spots including at least one control spot. 6. Apparatus for recording results of a fluorescent assay according to any one of claims 1 to 5 comprising: a sample holder; a source of exciting radiation positioned to illuminate a selectively fluorescent sample when held in the sample holder; macrophotographic recording means for recording fluorescent radiation emitted by a sample in the holder; and means for suppressing radiation of exciting wavelengths disposed between the sample holder and the recording means. 7. Apparatus according to claim 6 wherein the macrophotographic recording means is an instant development film and associated focussing lenses. 8. A process for recording the results of an assay according to any one of claims 1 to 5 comprising subjecting a sample selectively stained with a fluorochrome SUBSTITUTE SHEET to exciting radiation so that the fluorochrome is excited to emit radiation at its emitting wavelength, macrophotographically recording the emitted radiation on a photographic film and suppressing radiation of exciting wavelengths, between the sample and the film on a path. 9. A process for recording the results of an assay according to claim 8 comprising using an apparatus according to claim 6 or claim 7. SI T1TUTΞ SH

Inventors: DAROUGAR SOHRAB, DAROUGAR, SOHRAB
Applicants: DAROUGAR SOHRAB, DAROUGAR, SOHRAB
Application year: 1988
Main classification: G01N33
IPC codes: G01N21, G01N33